Related Experiment Videos

Onchocercal dermatitis: ultrastructural studies of microfilariae and host tissues, before and after treatment with

Insights

Diethylcarbamazine (DEC) treatment appears to alter Onchocerca volvulus microfilariae in the skin, making them vulnerable to host immune defenses. This leads to their destruction by immune cells like histiocytes and eosinophils.

Area of Science:

  • Onchocerca volvulus research
  • Dermatology
  • Parasitology

Background:

  • Onchocercal dermatitis is a severe skin condition caused by Onchocerca volvulus.
  • Diethylcarbamazine (DEC) is a treatment used for onchocerciasis.
  • The mechanism by which DEC affects microfilariae in the skin is not fully understood.

Purpose of the Study:

  • To investigate the ultrastructural changes in Onchocerca volvulus microfilariae after DEC treatment in patients with severe onchocercal dermatitis.
  • To elucidate the potential mechanisms of microfilarial destruction by host defenses.

Main Methods:

  • Skin specimens from four Cameroon patients were studied using light and electron microscopy.
  • Microfilariae were examined before and after DEC treatment.

Main Results:

  • Ultrastructural analysis revealed a widening of the electrolucent zone between the microfilarial cuticle and trilaminate membrane in degenerating microfilariae.
  • This widening may be due to DEC-induced release of cuticle components (e.g., collagen, mucopolysaccharide).
  • Granular deposits, possibly immune complexes, were observed between the cuticle and dermal collagen.

Conclusions:

  • DEC treatment likely "unmasks" microfilariae in the skin, enabling recognition and destruction by host immune cells (histiocytes, eosinophils).
  • Altered microfilarial cuticle may allow easier penetration by histiocytic and eosinophilic enzymes.
  • Widening of the electrolucent zone could also result from direct enzymatic action on DEC-killed microfilariae.

Related Concept Videos